#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5134023	F	Antiviral activity against SARS-Cov-2 infected in african green monkey Vero E6 cells assessed as inhibition of viral replication pretreated with compound for 1 hr followed by viral infection for 2 hrs measured after 24 hrs post infection by qRt-PCR analysis	Severe acute respiratory syndrome coronavirus 2	2	ALA5131463	organism-based format	Scientific Literature
2.	ALA5134025	F	Antiviral activity against SARS-Cov-2 infected in african green monkey Vero E6 cells assessed as inhibition of viral replication pretreated with compound for 1 hr followed by viral infection for 2 hrs measured after 24 hrs post infection in presence of wallichins C by qRt-PCR analysis	Severe acute respiratory syndrome coronavirus 2	1	ALA5131463	organism-based format	Scientific Literature
3.	ALA5134026	T	Cytotoxicity against African green monkey Vero E6 cells by CCK-8 assay	Chlorocebus sabaeus	2	ALA5131463	cell-based format	Scientific Literature
4.	ALA5134028	T	Cytotoxicity against African green monkey Vero E6 cells in presence of wallichins C by CCK-8 assay	Chlorocebus sabaeus	1	ALA5131463	cell-based format	Scientific Literature
5.	ALA5134029	T	Selectivity index, ratio for CC50 of African green monkey Vero E6 cells to EC50 for SARS-Cov-2 infected in african monkey Vero E6 cells		2	ALA5131463	assay format	Scientific Literature
6.	ALA5134031	T	Selectivity index, ratio of CC50 for African green monkey Vero cells in presence of wallichins D to EC50 for SARS-Cov-2 infected in african green monkey Vero E6 cells assessed as inhibition of viral replication in presence of wallichins C		1	ALA5131463	assay format	Scientific Literature
7.	ALA5134032	F	Antiviral activity against SARS-Cov-2 infected in human Calu-3 cells assessed as inhibition of viral replication pretreated with compound for 1 hr followed by viral infection for 2 hrs measured after 24 hrs post infection by qRt-PCR analysis	Severe acute respiratory syndrome coronavirus 2	2	ALA5131463	organism-based format	Scientific Literature
8.	ALA5134034	F	Antiviral activity against SARS-Cov-2 infected in human Calu-3 cells assessed as inhibition of viral replication pretreated with compound for 1 hr followed by viral infection for 2 hrs measured after 24 hrs post infection in presence of wallichins C by qRt-PCR analysis	Severe acute respiratory syndrome coronavirus 2	1	ALA5131463	organism-based format	Scientific Literature
9.	ALA5134035	T	Cytotoxicity against human Calu-3 cells by CCK-8 assay	Homo sapiens	2	ALA5131463	cell-based format	Scientific Literature
10.	ALA5134037	T	Cytotoxicity against human Calu-3 cells in presence of wallichins C by CCK-8 assay	Homo sapiens	1	ALA5131463	cell-based format	Scientific Literature
11.	ALA5134038	B	Binding affinity to SARS-CoV-2 3CL protease at 1.875 to 50 uM by SPR assay	Severe acute respiratory syndrome coronavirus 2	3	ALA5131463	single protein format	Scientific Literature
12.	ALA5134040	B	Binding affinity to SARS-CoV-2 3CL protease at 1.875 to 50 uM in presence of wallichins C by SPR assay	Severe acute respiratory syndrome coronavirus 2	1	ALA5131463	single protein format	Scientific Literature
13.	ALA5134041	B	Inhibition of SARS-CoV-2 3CL protease using MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 as flurogenic substrate pre-incubated with compound for 10 mins followed by substrate addition measured after 10 mins by FRET assay	Severe acute respiratory syndrome coronavirus 2	3	ALA5131463	single protein format	Scientific Literature
14.	ALA5134043	B	Inhibition of SARS-CoV-2 3CL protease using MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 as flurogenic substrate pre-incubated with compound for 10 mins followed by substrate addition measured after 10 mins in presence of wallichins C by FRET assay	Severe acute respiratory syndrome coronavirus 2	1	ALA5131463	single protein format	Scientific Literature
15.	ALA5134044	B	Binding affinity to TMPRSS2 (unknown origin) at 1.875 to 50 uM by SPR assay	Homo sapiens	2	ALA5131463	single protein format	Scientific Literature
16.	ALA5134045	B	Binding affinity to cathepsin B (unknown origin) at 1.875 to 50 uM by SPR assay	Homo sapiens	2	ALA5131463	single protein format	Scientific Literature
17.	ALA5134046	B	Binding affinity to SARS-CoV-2 full length Spike glycoprotein at 1.875 to 50 uM by SPR assay	Severe acute respiratory syndrome coronavirus 2	2	ALA5131463	single protein format	Scientific Literature
18.	ALA5134047	B	Binding affinity to ACE2 (unknown origin) at 1.875 to 50 uM by SPR assay	Homo sapiens	2	ALA5131463	single protein format	Scientific Literature
19.	ALA5134048	B	Binding affinity to SARS-CoV-2 Spike glycoprotein receptor-binding domain at 1.875 to 50 uM by SPR assay	Severe acute respiratory syndrome coronavirus 2	2	ALA5131463	single protein format	Scientific Literature
20.	ALA5134049	F	Antiviral activity against SARS CoV-2 VSV-delG pseudotype infected in african green monkey Vero E6 at 100 uM measured after 15 hrs post infection relative to control	Severe acute respiratory syndrome coronavirus 2	2	ALA5131463	organism-based format	Scientific Literature